Answer
Ranibizumab (Lucentis) is contraindicated in patients with hypersensitivity to ranibizumab or any excipient, active or suspected ocular or periocular infections, or active severe intraocular inflammation.
Sources for this answer
- Lucentis 10 mg/ml solution for injectionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.3 Contraindications · Version 33Document updated
Sources checked